ArticleOncology reports2021

Establishment and characterization of novel highly aggressive HER2‑positive and triple‑negative breast cancer cell lines.

Suyanee Thongchot et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.